Trials that use: P-values
New to this method? Read the tutorial →
10,201 results
- CNAP Accuracy in the Bariatric Surgery Population: Complete Statistical AnalysisIndependent statistical analysis of CNAP Accuracy in the Bariatric Surgery Population: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01896206).
- cNF-HFU2101Independent statistical analysis of HIFU Treatment of Cutaneous Neurofibromas in Neurofibromatosis Type 1: Safety and Efficacy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- CO2 Versus Air Insufflation for Single-balloon Enteroscopy: Complete Statistical AnalysisIndependent statistical analysis of CO2 Versus Air Insufflation for Single-balloon Enteroscopy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01758900).
- Coaching for Caregivers of Children With Spinal Cord Injury: Complete Statistical AnalysisIndependent statistical analysis of Coaching for Caregivers of Children With Spinal Cord Injury: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03898700).
- COACT-2Independent statistical analysis of Study of a Topical Gentamicin-Collagen Sponge Along With Systemic Antibiotic in Infected Diabetic Foot Ulcers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- COAPTIndependent statistical analysis of the COAPT trial (NCT01626079), evaluating MitraClip in symptomatic heart failure with functional mitral regurgitation, including trial design, primary safety analysis, recurrent hospitalization, win ratio methodology, and statistical interpretation.
- COASTIndependent statistical analysis of OPT-302 With Aflibercept in Neovascular Age-related Macular Degeneration (nAMD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04757636).
- COAST-VIndependent statistical analysis of A Study of Ixekizumab (LY2439821) in bDMARD-Naive Participants With Radiographic Axial Spondyloarthritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Coated VICRYL* Plus Suture Compared to Chinese Silk in Scheduled Breast Cancer Surgery: Complete Statistical AnalysisIndependent statistical analysis of Coated VICRYL* Plus Suture Compared to Chinese Silk in Scheduled Breast Cancer Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- COBALTIndependent statistical analysis of Safety & Efficacy Study Evaluating the Combination of Bevasiranib & Lucentis Therapy in Wet AMD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Cobiprostone Prevention of NSAID-induced Gastroduodenal Injury: Complete Statistical AnalysisIndependent statistical analysis of Cobiprostone Prevention of NSAID-induced Gastroduodenal Injury: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00597818).
- Cocaine and Zolmitriptan: Complete Statistical AnalysisIndependent statistical analysis of Cocaine and Zolmitriptan: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05019430).
- Cochlear Implantation for Treatment of Single-sided Deafness: Complete Statistical AnalysisIndependent statistical analysis of Cochlear Implantation for Treatment of Single-sided Deafness: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02532972).
- Cocoa Flavanols for Modulating Immune Response and Accelerating Recovery: Complete Statistical AnalysisIndependent statistical analysis of Cocoa Flavanols for Modulating Immune Response and Accelerating Recovery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03123068).
- COCOA-PADIndependent statistical analysis of Cocoa to Improve Walking Performance in Peripheral Artery Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02876887).
- COCOVIndependent statistical analysis of Care Outcomes for Chiropractic Outpatient Veterans: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03254719).
- CODAIndependent statistical analysis of The Comparison of Outcomes of Antibiotic Drugs and Appendectomy (CODA) Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Code SepsisIndependent statistical analysis of Effects of Code Sepsis Implementation on Emergency Department (ED) Sepsis Care: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- CodeBreaK 200Independent statistical analysis of CodeBreaK 200, a randomized phase 3 trial comparing AMG 510 (sotorasib) with docetaxel in KRAS G12C-mutated advanced or metastatic NSCLC, including progression-free survival, hazard ratios, confidence intervals, log-rank…
- CODEXIndependent statistical analysis of Evaluation of Efficacy on Exercise Tolerance of Symbicort (Budesonide/Formoterol) Compared to Placebo and Oxis in Patients With Severe COPD: primary endpoint results, effect estimate with confidence interval, sample-size…
- CoFAR7Independent statistical analysis of Baked Egg or Egg Oral Immunotherapy for Children With Egg Allergy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- COG STIMIndependent statistical analysis of Management of Cognitive Difficulties After Cancer Treatments in Women Treated for Breast Cancer: Feasibility Study (Step 1 of the Cog-Stim Protocol): primary endpoint results, effect estimate with confidence…
- Cognition Platform Study in Participants at Risk for Alzheimer’s Disease (AD) (MK-0000-413): Complete Statistical AnalysisIndependent statistical analysis of Cognition Platform Study in Participants at Risk for Alzheimer's Disease (AD) (MK-0000-413): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Cognitive Behavioral Therapy (CBT) for Anxiety Disorders in Autism: Adapting Treatment for Adolescents: Complete Statistical AnalysisIndependent statistical analysis of Cognitive Behavioral Therapy (CBT) for Anxiety Disorders in Autism: Adapting Treatment for Adolescents: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Cognitive Behavioral Therapy for Adolescent Binge Eating and Loss of Control Eating: Complete Statistical AnalysisIndependent statistical analysis of Cognitive Behavioral Therapy for Adolescent Binge Eating and Loss of Control Eating: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Cognitive Behavioral Treatments for Post-traumatic Stress Disorder (PTSD) Sleep Disturbance: Complete Statistical AnalysisIndependent statistical analysis of Cognitive Behavioral Treatments for Post-traumatic Stress Disorder (PTSD) Sleep Disturbance: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00108628).
- Cognitive Effects of Inhalational Versus Intravenous General Anesthesia in the Elderly: Complete Statistical AnalysisIndependent statistical analysis of Cognitive Effects of Inhalational Versus Intravenous General Anesthesia in the Elderly: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Cognitive Enhancement Through Computerized Training: Complete Statistical AnalysisIndependent statistical analysis of Cognitive Enhancement Through Computerized Training: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04244032).
- Cognitive Remediation for Cocaine Dependence: Complete Statistical AnalysisIndependent statistical analysis of Cognitive Remediation for Cocaine Dependence: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01393457).
- Cognitive Remediation With D-Cycloserine: Complete Statistical AnalysisIndependent statistical analysis of Cognitive Remediation With D-Cycloserine: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01399866).
- Cognitive Stimulation Therapy for Dementia: A Two-Armed Pragmatic Trial: Complete Statistical AnalysisIndependent statistical analysis of Cognitive Stimulation Therapy for Dementia: A Two-Armed Pragmatic Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05860127).
- Cognitive Training for Nicotine Dependence: Complete Statistical AnalysisIndependent statistical analysis of Cognitive Training for Nicotine Dependence: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01252966).
- Cognitive Training Trial: Complete Statistical AnalysisIndependent statistical analysis of Cognitive Training Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01133418).
- Cognitive Training With and Without tDCS to Improve Cognition in HIV: Complete Statistical AnalysisIndependent statistical analysis of Cognitive Training With and Without tDCS to Improve Cognition in HIV: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Cognitive-Behavioral Therapy and Escitalopram for Generalized Anxiety Disorder(GAD): Complete Statistical AnalysisIndependent statistical analysis of Cognitive-Behavioral Therapy and Escitalopram for Generalized Anxiety Disorder(GAD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00219349).
- Cognitive-Behavioral Therapy in Veterans With Schizophrenia: Complete Statistical AnalysisIndependent statistical analysis of Cognitive-Behavioral Therapy in Veterans With Schizophrenia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00688259).
- COGNUTRIN in Breast Cancer Survivors: Complete Statistical AnalysisIndependent statistical analysis of COGNUTRIN in Breast Cancer Survivors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01823991).
- CogSMART-PDIndependent statistical analysis of Cognitive Rehabilitation for PD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03335150).
- CogXergaming to Promote Physical Activity and Cognitive Function in Frail Older Adults: Complete Statistical AnalysisIndependent statistical analysis of CogXergaming to Promote Physical Activity and Cognitive Function in Frail Older Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Cold Laser: A Modality to Promote Vulvar Healing and Pain Relief: Complete Statistical AnalysisIndependent statistical analysis of Cold Laser: A Modality to Promote Vulvar Healing and Pain Relief: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- ColdPlay2Independent statistical analysis of Evaluation of Effect of CryoBalloon Focal Ablation System on Human Esophageal Epithelium: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Colesevelam Versus Placebo in the Treatment of Nonalcoholic Steatohepatitis: Complete Statistical AnalysisIndependent statistical analysis of Colesevelam Versus Placebo in the Treatment of Nonalcoholic Steatohepatitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01066364).
- Collaboration Live: Complete Statistical AnalysisIndependent statistical analysis of Collaboration Live: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04243369).
- Collaborative Care for Alcohol Use Disorders in the Patient-centered Medical Home: Complete Statistical AnalysisIndependent statistical analysis of Collaborative Care for Alcohol Use Disorders in the Patient-centered Medical Home: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- ColumbusIndependent statistical analysis of Study to Assess the Efficacy and Safety of AZD1981 in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD): primary endpoint results, effect estimate with confidence interval,…
- Combination Antibiotic Treatment for Reactive Arthritis Caused by Chlamydia Bacteria: Complete Statistical AnalysisIndependent statistical analysis of Combination Antibiotic Treatment for Reactive Arthritis Caused by Chlamydia Bacteria: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00351273).
- Combination Chemotherapy and Bevacizumab in Treating Patients With Advanced Neuroendocrine Tumors: Complete Statistical AnalysisIndependent statistical analysis of Combination Chemotherapy and Bevacizumab in Treating Patients With Advanced Neuroendocrine Tumors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Combination Chemotherapy and Dasatinib in Treating Participants With Philadelphia Positive or BCR-ABL Positive Acute Lymphoblastic Leukemia.: Complete Statistical AnalysisIndependent statistical analysis of Combination Chemotherapy and Dasatinib in Treating Participants With Philadelphia Positive or BCR-ABL Positive Acute Lymphoblastic Leukemia.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Combination Chemotherapy and Pegfilgrastim in Treating Patients With Previously Untreated Germ Cell Tumors: Complete Statistical AnalysisIndependent statistical analysis of Combination Chemotherapy and Pegfilgrastim in Treating Patients With Previously Untreated Germ Cell Tumors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Combination Chemotherapy and Peripheral Blood Stem Cell Transplant Followed By Aldesleukin and Sargramostim in Treating Patients With Inflammatory Stage IIIB or Metastatic Stage IV Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Combination Chemotherapy and Peripheral Blood Stem Cell Transplant Followed By Aldesleukin and Sargramostim in Treating Patients With Inflammatory Stage IIIB or Metastatic Stage IV Breast Cancer: primary endpoint…